| Wednesday, August 15th

Patient information seminars in Stockholm (11.9.2018) and in Helsinki (4.10.2018)

EPDA | Thursday, January 18th

Parkinson’s prevalence expected to increase by 18% by 2025

Read More
Herantis Pharma | Wednesday, September 27th

Patient recruitment started and first patient consented in the CDNF Phase I-II clinical study

Read more
TreatER | Friday, June 30th

TreatER Horizon 2020 program website launched

EPDA | Wednesday, May 24th

How wearable devices can help people with Parkinson’s communicate better with their doctors

Read More
EPDA | Thursday, April 13th

200 years of Parkinson’s disease: still no cure, but EU policy must drive improvements in quality of life

Read more
EPDA | Tuesday, April 11th

World Parkinson’s Day: #Unite for Parkinsons social media campaign

Read more
Herantis Pharma | Thursday, March 23rd

Herantis Pharma’s clinical study with CDNF in Parkinson’s disease authorized in Sweden

Read more
Herantis Pharma | Monday, December 12th

Herantis Pharma’s Parkinson study wins EUR 6.0 million grant from the European Union Horizon 2020 program

Read more